CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.

scientific article published in November 2008

CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/GPS.2038
P698PubMed publication ID18464287
P5875ResearchGate publication ID5387888

P50authorBreno Satler DinizQ38800234
Marcia RadanovicQ45289063
Paula Villela NunesQ47378254
Monica S YassudaQ64498850
Orestes V ForlenzaQ91970111
Danilo T BorelliQ117261113
P2093author name stringIzabella D Abreu
P2860cites workA rating scale for depressionQ24564540
“Mini-mental state”Q25938989
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseQ27860795
Mild cognitive impairment: clinical characterization and outcomeQ28140626
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteriaQ29614410
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairmentQ29615678
Current concepts in mild cognitive impairmentQ34104314
Evaluation of a mental test score for assessment of mental impairment in the elderlyQ34216117
Cerebral blood flow in dementiaQ34518886
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentQ35868499
Guaranteed stimulus-processing in the evaluation of memory and learningQ38501742
CAMCOG as a screening instrument for dementia: the Odense study. Cambridge Cognitive ExaminationQ44456828
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms.Q45194604
Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: results from the European Harmonization Project for Instruments in DementiaQ47643386
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International WorkshopQ48342894
Decline across different domains of cognitive function in normal ageing: results of a longitudinal population-based study using CAMCOG.Q50664830
CAMCOG--a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample.Q51041842
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.Q51183354
Mini-mental State Examination performance in mild cognitive impairment subtypes.Q51903669
Screening for mild cognitive impairment in elderly ambulatory patients with cognitive complaints.Q51922680
The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil.Q51924667
The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test.Q51985663
CAMDEX, can it be more efficient? Observational study on the contribution of four screening measures to the diagnosis of dementia by a memory clinic team.Q52021789
A short screening instrument for poststroke dementia : the R-CAMCOG.Q52026030
Clock drawing in Alzheimer's disease. A novel measure of dementia severity.Q52064819
CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.Q52077039
MCI is a clinically useful concept.Q53380350
[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer diseaseQ60451990
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectmild cognitive impairmentQ1472703
dementiaQ83030
cognitive dysfunctionQ57859955
P304page(s)1127-1133
P577publication date2008-11-01
P1433published inInternational Journal of Geriatric PsychiatryQ6051406
P1476titleCAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
P478volume23

Reverse relations

cites work (P2860)
Q42662164A score based on screening tests to differentiate mild cognitive impairment from subjective memory complaints
Q34021001Application study of quick cognitive screening test in identifying mild cognitive impairment
Q37407597Applications of technology in neuropsychological assessment
Q51847162Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education?
Q50607336Clock Drawing Test and the diagnosis of amnestic mild cognitive impairment: can more detailed scoring systems do the work?
Q37389846Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly.
Q33795233Comparison of the diagnostic accuracy of neuropsychological tests in differentiating Alzheimer's disease from mild cognitive impairment: can the montreal cognitive assessment be better than the cambridge cognitive examination?
Q46964545Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults.
Q51030241Detecting prodromal Alzheimer's disease in mild cognitive impairment: utility of the CAMCOG and other neuropsychological predictors
Q51135677Diagnostic transitions in mild cognitive impairment subtypes.
Q37022147Feasibility and validity of dementia assessment by trained community health workers based on Clinical Dementia Rating
Q34600572Internet-based screening for dementia risk
Q50652639Is the Cambridge Cognitive Examination - revised a good tool for detection of dementia in illiterate Brazilian older adults?
Q37582563Is the Clock Drawing Test a screening tool for the diagnosis of mild cognitive impairment? A systematic review
Q49031432Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study
Q38125621Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia.
Q51873283Mild cognitive impairment: cognitive screening or neuropsychological assessment?
Q47146178Neuropsychological performance differences between two groups of probable-AD patients from different areas of Brazil
Q51043584Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains.
Q48912689Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?
Q48745229Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up
Q51782041Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement.
Q47378206Psychometric characteristics of the Rivermead Behavioural Memory Test (RBMT) as an early detection instrument for dementia and mild cognitive impairment in Brazil
Q55514334Qualitative analysis and identification of pattern of errors in Clock Drawing Tests of community-dwelling older adults.
Q48092158Sensitivity and specificity of a briefer version of the Cambridge Cognitive Examination (CAMCog-Short) in the detection of cognitive decline in the elderly: An exploratory study
Q48329873Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression.
Q46119787Specific algorithm method of scoring the Clock Drawing Test applied in cognitively normal elderly.
Q86325537Spectral analyses of systolic blood pressure and heart rate variability and their association with cognitive performance in elderly hypertensive subjects
Q51871520The Clock Drawing Test--Modified and Integrated Approach (CDT-MIA) as an instrument for detecting mild cognitive impairment in a specialized outpatient setting.
Q37611114The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds.
Q37764258The diagnostic accuracy of dementia-screening instruments with an administration time of 10 to 45 minutes for use in secondary care: a systematic review
Q47812130Validation of the Six-Item Screener to screen for cognitive impairment in primary care settings in China
Q38380106Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education